Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441090
Status:
COMPLETED
Last Update Posted:
2018-03-07
First Post:
2007-02-27
Brief Title:
Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura ITP
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Organization Data
Organization:
Eisai Inc
Class:
INDUSTRY
Study ID:
AKR-501-CL-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eisai Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None